PHYTOTHER RES 润色咨询

PHYTOTHERAPY RESEARCH

出版年份:1987 年文章数:3253 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:12.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2022-08-02 有时候有石猴

    审稿速度:3.0 | 投稿命中率:75.0
    偏重的研究方向:神经炎症
    经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。
    7.9一审修回。
    五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。
    写一下过程记录一下。希望二审有好消息。

    11

    展开11条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2023-08-10 ms1000000241037126 来自北京

    请问各位WB原图是提供文中的就好,还是原始重复数据都要?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2025-04-10 ms9000001184392236 来自重庆

    偏重的研究方向:中药
    经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2025-11-06 ms8000002977722177 来自北京

    投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,
    然后看到大家都这样,我也就放心了😭
    效率低到离谱呀。

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2024-11-30 ms2000001788822132 来自上海

    不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof
    催也催了好几遍了,但是统统不回复,真难😭

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2023-08-09 fireflysky6 来自湖北省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤药理
    经验分享:submitted: april 25, 2023
    final revisions submitted: july 20, 2023
    accepted: august 6, 2023
    第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。
    第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。
    8月9日发邮件确认license agreement,开始in production,有doi号。

    13

    展开13条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2025-07-07 ms8000001820193609 来自上海

    有同学投稿后是in screening状态吗?

    13

    展开13条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2024-03-01 ms6000001594127539 来自伦敦

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤;天然产物;综述
    经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。
    初次提交:20230901;
    审稿意见返回,给了三个月的时间大修:20231120;
    返修回去,送回审稿人:20240208;
    一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;
    二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;
    接收:20240229。

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2025-05-10 ms2000000131334501 来自江苏省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:药理;炎症
    经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1236226, encodeId=fe3e1236226c3, content=审稿速度:3.0 | 投稿命中率:75.0<br>偏重的研究方向:神经炎症<br>经验分享:4.4投稿后就是under review状态。中间焦急等待三个月,期间想过发催稿信,但还是忍住没发。<br>7.9一审修回。<br>五个审稿人都比较友好,有个要补实验。审稿人对语言要求较高,现补完送去润色中。<br>写一下过程记录一下。希望二审有好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Tue Aug 02 22:03:25 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2152164, encodeId=2f5e2152164d3, content=请问各位WB原图是提供文中的就好,还是原始重复数据都要?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=062e5556814, createdName=ms1000000241037126, createdTime=Thu Aug 10 20:10:15 CST 2023, time=2023-08-10, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259947, encodeId=d707225994e33, content=偏重的研究方向:中药<br>经验分享:想请问一下大家的投稿是不是一直都是under review呀,从投稿到现在6天了还没有变, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21aa9174585, createdName=ms9000001184392236, createdTime=Thu Apr 10 21:19:04 CST 2025, time=2025-04-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2287897, encodeId=923a228e897cb, content=投出心理阴影!熬了无数夜改语言、补机理实验,好不容易等了 5 个月收到接收通知,以为终于熬出头了。结果卡住了,邮件催了三四遍,石沉大海连个自动回复都没有,<br>然后看到大家都这样,我也就放心了😭<br>效率低到离谱呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722177, createdTime=Thu Nov 06 23:32:06 CST 2025, time=2025-11-06, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2240113, encodeId=1b5e224011399, content=不知道是我运气不好还怎么回事,好慢呀,慢的我想爆粗口,接收大半年了,也不proof<br>催也催了好几遍了,但是统统不回复,真难😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 21:59:54 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151914, encodeId=e8ea21519149a, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤药理<br>经验分享:submitted: april 25, 2023<br>final revisions submitted: july 20, 2023<br>accepted: august 6, 2023<br>第一次大修回来是5月31日,7个审稿人,还有编辑的差不多30条修改意见,算是8个审稿人。<br>第二次修回是7月15日,审稿人5又提了10来个问题,7月20号修回去,8月6日接收。<br>8月9日发邮件确认license agreement,开始in production,有doi号。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1281645731, createdName=fireflysky6, createdTime=Wed Aug 09 11:02:48 CST 2023, time=2023-08-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2272406, encodeId=b22222e2406c8, content=有同学投稿后是in screening状态吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=999b9158850, createdName=ms8000001820193609, createdTime=Mon Jul 07 16:24:26 CST 2025, time=2025-07-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2190362, encodeId=d48c2190362be, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤;天然产物;综述<br>经验分享:投的是一篇综述,非邀稿,全程三个审稿人,历时6个月。<br>初次提交:20230901;<br>审稿意见返回,给了三个月的时间大修:20231120;<br>返修回去,送回审稿人:20240208;<br>一修意见返回:20240225,编辑让小修:一位审稿人提出了一个文章结构的小问题;因为没有提交标记稿件的位置,只提交了clean manuscript,另一位审稿人建议重新提交标记稿;<br>二修提交:20240227,当天under review,感觉还是有送审稿人的,但还挺快的;<br>接收:20240229。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6aa8254344, createdName=ms6000001594127539, createdTime=Fri Mar 01 11:21:24 CST 2024, time=2024-03-01, status=1, ipAttribution=伦敦), GetPortalCommentsPageByObjectIdResponse(id=2264351, encodeId=b32c226435166, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:药理;炎症<br>经验分享:投稿4个多月还在Under review,发询问进度的邮件编辑也没回复,还要等多久~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f38f8199765, createdName=ms2000000131334501, createdTime=Sat May 10 09:12:42 CST 2025, time=2025-05-10, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2257155, encodeId=69bc225e155da, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向:药理<br>经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fba6502217, createdName=ms1000000770851243, createdTime=Fri Mar 21 17:44:55 CST 2025, time=2025-03-21, status=1, ipAttribution=四川省)]
    2025-03-21 ms1000000770851243 来自四川省

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向:药理
    经验分享:投稿三天分配了一个不相关领域的编辑,拖了两个多月才给初审结果,发邮件不回,垃圾期刊

    3

    展开3条回复
共414条页码: 1/42页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分